Cogent Biosciences (COGT) Short Interest Ratio & Short Volume → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free COGT Stock Alerts $7.44 -0.03 (-0.40%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cogent Biosciences Short Interest DataCurrent Short Volume12,040,000 sharesPrevious Short Volume12,470,000 sharesChange Vs. Previous Month-3.45%Dollar Volume Sold Short$78.26 millionShort Interest Ratio / Days to Cover5.8Last Record DateApril 30, 2024Outstanding Shares95,613,000 sharesPercentage of Shares Shorted12.59%Today's Trading Volume785,400 sharesAverage Trading Volume1,880,214 sharesToday's Volume Vs. Average42% Short Selling Cogent Biosciences ? Sign up to receive the latest short interest report for Cogent Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCOGT Short Interest Over TimeCOGT Days to Cover Over TimeCOGT Percentage of Float Shorted Over Time Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company Cogent Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,040,000 shares $78.26 million -3.5%N/A5.8 $6.50 4/15/202412,470,000 shares $81.06 million +15.0%N/A5.9 $6.50 3/31/202410,840,000 shares $72.84 million +12.6%N/A5 $6.72 3/15/20249,630,000 shares $67.89 million +6.2%N/A4.5 $7.05 2/29/20249,070,000 shares $63.49 million +45.4%N/A3.5 $7.00 2/15/20246,240,000 shares $55.41 million +23.8%N/A2.5 $8.88 Get the Latest News and Ratings for COGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20245,040,000 shares $22.33 million -5.6%N/A2.6 $4.43 1/15/20245,340,000 shares $27.02 million -6.3%N/A3 $5.06 12/31/20235,700,000 shares $33.52 million -22.3%N/A3.5 $5.88 12/15/20237,340,000 shares $35.82 million -8.5%N/A4.8 $4.88 11/30/20238,020,000 shares $61.51 million +1.1%N/A6.3 $7.67 11/15/20237,930,000 shares $60.90 million +23.0%N/A9.4 $7.68 10/31/20236,450,000 shares $52.63 million +6.6%N/A8.3 $8.16 10/15/20236,050,000 shares $57.60 million +4.1%N/A8.3 $9.52 9/30/20235,810,000 shares $56.65 million -9.2%N/A8.5 $9.75 9/15/20236,400,000 shares $75.26 million -4.3%N/A9.5 $11.76 8/31/20236,690,000 shares $81.68 million +4.9%N/A9.8 $12.21 8/15/20236,380,000 shares $78.41 million +24.9%N/A8.7 $12.29 7/31/20235,110,000 shares $66.38 million +4.5%N/A6.9 $12.99 7/15/20234,890,000 shares $61.27 million -7.2%N/A7 $12.53 6/30/20235,270,000 shares $62.40 million -0.9%N/A7.2 $11.84 6/15/20235,320,000 shares $67.09 million +14.7%N/A7 $12.61 5/31/20234,640,000 shares $54.47 million +2.9%N/A6.5 $11.74 5/15/20234,510,000 shares $53.67 million -15.1%N/A7 $11.90 4/30/20235,310,000 shares $57.14 million -5.9%N/A8.5 $10.76 4/15/20235,640,000 shares $57.92 million -8.6%N/A9.5 $10.27 3/31/20236,170,000 shares $66.57 million -3.3%N/A10 $10.79 3/15/20236,380,000 shares $77.58 million +15.2%N/A9.9 $12.16 2/28/20235,540,000 shares $73.29 million +9.5%N/A7.8 $13.23 2/15/20235,060,000 shares $69.42 million +1.6%N/A6.8 $13.72 1/31/20234,980,000 shares $75.00 million -16.2%N/A6.5 $15.06 1/15/20235,940,000 shares $77.40 million +1.9%N/A7.5 $13.03 12/30/20225,830,000 shares $67.39 million +19.7%N/A7.8 $11.56 12/15/20224,870,000 shares $58.25 million -4.7%N/A6.4 $11.96 11/30/20225,110,000 shares $64.28 million +7.1%N/A6.4 $12.58 11/15/20224,770,000 shares $55.86 million +1.9%N/A5.7 $11.71 10/31/20224,680,000 shares $63.88 million -4.9%N/A4.7 $13.65 10/15/20224,920,000 shares $66.96 million -8.9%N/A4.8 $13.61 9/30/20225,400,000 shares $80.57 million +42.5%N/A5.2 $14.92 9/15/20223,790,000 shares $62.27 million +17.7%N/A3.4 $16.43He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs COGT Short Interest - Frequently Asked Questions What is Cogent Biosciences' current short interest? Short interest is the volume of Cogent Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 12,040,000 shares of COGT short. Learn More on Cogent Biosciences' current short interest. What is a good short interest ratio for Cogent Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COGT shares currently have a short interest ratio of 6.0. Learn More on Cogent Biosciences's short interest ratio. Which institutional investors are shorting Cogent Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cogent Biosciences: PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cogent Biosciences' short interest increasing or decreasing? Cogent Biosciences saw a drop in short interest in April. As of April 30th, there was short interest totaling 12,040,000 shares, a drop of 3.4% from the previous total of 12,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cogent Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cogent Biosciences: CureVac (4.79%), Wave Life Sciences Ltd. (2.27%), AnaptysBio, Inc. (18.06%), Nuvation Bio Inc. (2.51%), Sage Therapeutics, Inc. (16.60%), GH Research PLC (5.05%), Calliditas Therapeutics AB (publ) (0.03%), Nurix Therapeutics, Inc. (14.04%), Phibro Animal Health Co. (2.76%), Aurinia Pharmaceuticals Inc. (8.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cogent Biosciences stock? Short selling COGT is an investing strategy that aims to generate trading profit from Cogent Biosciences as its price is falling. COGT shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cogent Biosciences? A short squeeze for Cogent Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COGT, which in turn drives the price of the stock up even further. How often is Cogent Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COGT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CVAC Short Squeeze WVE Short Squeeze ANAB Short Squeeze NUVB Short Squeeze SAGE Short Squeeze GHRS Short Squeeze CALT Short Squeeze NRIX Short Squeeze PAHC Short Squeeze AUPH Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COGT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club